Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA ...

The EU faces a surge in new opioids and designer drugs, while the U.S. fast-tracks rare disease drugs. Brazil tackles bird ...

Recent health news highlights include a halt in new measles cases in Texas, efforts to accelerate the approval of drugs for ...

Shares of Robinhood (HOOD) are trading up again on Friday ahead of tonight’s S&P 500 rebalance, marking the sixth consecutive ...